ArticleCancers2021

Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors-A Retrospective, Real-World Cohort Study.

Maximilian Haist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.